PortfoliosLab logoPortfoliosLab logo
RDY vs. HDB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RDY vs. HDB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dr. Reddy's Laboratories Limited (RDY) and HDFC Bank Limited (HDB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RDY achieves a -5.27% return, which is significantly higher than HDB's -33.85% return. Over the past 10 years, RDY has underperformed HDB with an annualized return of 4.69%, while HDB has yielded a comparatively higher 5.46% annualized return.


RDY

1D
-0.45%
1M
-1.41%
YTD
-5.27%
6M
-5.14%
1Y
-15.30%
3Y*
5.74%
5Y*
-1.12%
10Y*
4.69%

HDB

1D
1.51%
1M
-2.70%
YTD
-33.85%
6M
-32.66%
1Y
-33.11%
3Y*
-7.62%
5Y*
-7.24%
10Y*
5.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RDY vs. HDB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RDY
Dr. Reddy's Laboratories Limited
-5.27%-10.53%14.13%36.47%-19.74%-7.33%76.80%8.45%0.37%-16.46%
HDB
HDFC Bank Limited
-33.85%17.07%-2.54%0.16%7.39%-9.29%14.03%22.58%2.44%68.50%

Correlation

The correlation between RDY and HDB is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Jul 20, 2001

0.32

Fundamentals

Market Cap

RDY:

$11.10B

HDB:

$41.47B

EPS

RDY:

₹51.45

HDB:

₹179.48

PE Ratio

RDY:

24.75

HDB:

12.89

PEG Ratio

RDY:

1.04

HDB:

0.19

PS Ratio

RDY:

3.15

HDB:

1.98

PB Ratio

RDY:

2.88

HDB:

0.69

Total Revenue (TTM)

RDY:

₹337.10B

HDB:

₹5.00T

Gross Profit (TTM)

RDY:

₹177.79B

HDB:

₹2.86T

EBITDA (TTM)

RDY:

₹74.65B

HDB:

₹1.03T

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RDY vs. HDB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDY
RDY Risk / Return Rank: 1111
Overall Rank
RDY Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
RDY Sortino Ratio Rank: 1313
Sortino Ratio Rank
RDY Omega Ratio Rank: 1414
Omega Ratio Rank
RDY Calmar Ratio Rank: 1010
Calmar Ratio Rank
RDY Martin Ratio Rank: 66
Martin Ratio Rank

HDB
HDB Risk / Return Rank: 44
Overall Rank
HDB Sharpe Ratio Rank: 11
Sharpe Ratio Rank
HDB Sortino Ratio Rank: 22
Sortino Ratio Rank
HDB Omega Ratio Rank: 33
Omega Ratio Rank
HDB Calmar Ratio Rank: 99
Calmar Ratio Rank
HDB Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDY vs. HDB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and HDFC Bank Limited (HDB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RDYHDBDifference
Sharpe ratioReturn per unit of total volatility

+0.67

Sortino ratioReturn per unit of downside risk

+1.21

Omega ratioGain probability vs. loss probability

0.88

0.75

+0.14

Calmar ratioReturn relative to maximum drawdown

-0.84

-0.85

+0.01

Martin ratioReturn relative to average drawdown

-1.52

-1.74

+0.22

RDY vs. HDB - Sharpe Ratio Comparison

The current RDY Sharpe Ratio is -0.75, which is higher than the HDB Sharpe Ratio of -1.42. The chart below compares the historical Sharpe Ratios of RDY and HDB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RDY vs. HDB - Drawdown Comparison

The maximum RDY drawdown since its inception was -60.62%, smaller than the maximum HDB drawdown of -67.93%. Use the drawdown chart below to compare losses from any high point for RDY and HDB.


Loading charts...

Drawdown Indicators


RDYHDBDifference

Max Drawdown

Largest peak-to-trough decline

-60.62%

-67.93%

+7.31%

Max Drawdown (1Y)

Largest decline over 1 year

-20.65%

-40.98%

+20.33%

Max Drawdown (3Y)

Largest decline over 3 years

-26.61%

-40.98%

+14.37%

Max Drawdown (5Y)

Largest decline over 5 years

-35.25%

-40.98%

+5.73%

Max Drawdown (10Y)

Largest decline over 10 years

-47.13%

-54.28%

+7.15%

Current Drawdown

Current decline from peak

-20.54%

-38.00%

+17.46%

Average Drawdown

Average peak-to-trough decline

-21.92%

-13.80%

-8.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.31%

20.09%

-6.78%

Volatility

RDY vs. HDB - Volatility Comparison

The current volatility for Dr. Reddy's Laboratories Limited (RDY) is 6.24%, while HDFC Bank Limited (HDB) has a volatility of 8.37%. This indicates that RDY experiences smaller price fluctuations and is considered to be less risky than HDB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RDYHDBDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.24%

8.37%

-2.13%

Volatility (6M)

Calculated over the trailing 6-month period

17.41%

21.09%

-3.68%

Volatility (1Y)

Calculated over the trailing 1-year period

23.20%

24.57%

-1.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.26%

26.84%

-3.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.58%

29.07%

-2.49%

Dividends

RDY vs. HDB - Dividend Comparison

RDY's dividend yield for the trailing twelve months is around 0.69%, less than HDB's 3.51% yield.


PositionTTM20252024202320222021202020192018201720162015
HDB
HDFC Bank Limited
3.51%2.32%2.19%2.06%1.70%0.81%0.00%0.17%0.55%0.49%0.66%0.58%
RDY
Dr. Reddy's Laboratories Limited
0.69%0.65%0.60%1.39%1.48%1.04%0.46%0.71%0.00%0.78%0.62%0.63%

Financials

RDY vs. HDB - Financials Comparison

This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and HDFC Bank Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00B400.00B600.00B800.00B1.00T1.20T1.40T20222023202420252026
76.33B
1.19T
(RDY) Total Revenue
(HDB) Total Revenue
Values in INR except per share items

RDY vs. HDB - Profitability Comparison

The chart below illustrates the profitability comparison between Dr. Reddy's Laboratories Limited and HDFC Bank Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
44.8%
58.4%
Portfolio components
RDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a gross profit of 34.22B and revenue of 76.33B. Therefore, the gross margin over that period was 44.8%.

HDB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HDFC Bank Limited reported a gross profit of 693.21B and revenue of 1.19T. Therefore, the gross margin over that period was 58.4%.

RDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported an operating income of 473.25M and revenue of 76.33B, resulting in an operating margin of 0.6%.

HDB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HDFC Bank Limited reported an operating income of 281.02B and revenue of 1.19T, resulting in an operating margin of 23.7%.

RDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a net income of 2.24B and revenue of 76.33B, resulting in a net margin of 2.9%.

HDB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HDFC Bank Limited reported a net income of 206.67B and revenue of 1.19T, resulting in a net margin of 17.4%.


Frequently Asked Questions


RDY and HDB have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HDB has higher volatility (8.37%) compared to RDY (6.24%). In terms of maximum drawdown, RDY dropped -60.62% vs HDB's -67.93%.

RDY currently has the higher Sharpe Ratio (-0.75 vs -1.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RDY and HDB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer